Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Shareholder Notice: Lawsuit Alleges Misleading Statements
An investor, who purchased shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA), filed a lawsuit over alleged violations of Federal Securities Laws by Reata Pharmaceuticals, Inc..
View full press release